TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
CELC

Celcuity LLC

Healthcare · Biotechnology

79.50$ +0.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow CELC
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – – –
– +25.2% +43.3% +113.0% +52.0% +13.7% -21.4% -30.4% -32.3% -8.9% +28.5%
– +231.5% +366.8% +33.6% -10.9% +69.4% +48.0% +77.7% +5.7% +42.6% +206.0%
– +231.5% +594.6% -10.4% -7.0% +62.7% +48.0% +95.1% – – –
– -3.6% -163.0% – – – +358.0% -245.4% – +375.4% -114.5%
– -48.2% +486.4% +162.5% -39.6% -76.5% -8.4% +93.9% -38.5% +155.9% -0.4%
– -48.2% +70,743.2% – -55.3% -101.0% -8.9% +176,847.6% -96.5% +1,159.3% +1.6%
– – – – – – – – – – –
– -2.2% +548.5% -100.2% – -77.4% +36.3% +116,560.8% – – –
– +0.0% +0.0% -100.0% +72.4% +0.7% – +36.0% -100.0% – +276.1%
– -22.6% +725.9% -99.2% +9.6% -46.8% +67,336.7% +29.3% -46.1% +113.2% +160.5%
– -71.2% -507.6% – -78.9% -354.3% – -182.2% – -233.8% –
– – – – – – – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?